atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
atai Life Sciences (ATAI) Misses Q3 EPS by 1c; Reports Cash and Cash Equivalents of $430.3M
November 15, 2021 7:12 AM ESTatai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.
... More